Splenectomy and azygoportal disconnection decreases the risk of hepatocellular carcinoma for cirrhosis patients with portal hypertension bleeding: a 10-year retrospective follow-up study based on the inverse probability of treatment weighting method
ConclusionsConsidering the better postoperative survival and the ability to prevent HCC in CPH patients with gastroesophageal variceal bleeding and secondary hypersplenism, LSD is worth popularization in situations where liver donors are scarce.
Source: Journal of Gastroenterology - Category: Gastroenterology Source Type: research
More News: Bleeding | Cancer & Oncology | Carcinoma | Cirrhosis | Gastroenterology | Hepatocellular Carcinoma | Hypertension | Laparoscopy | Liver | Liver Cancer | Pancreas | Pancreatic Cancer | Splenectomy | Study | Urology & Nephrology